Table 1 Characteristics of children and adolescents participating in the main test (N = 26)
Age in years; M (SD) | 9.92 (6.3) | |
|---|---|---|
Age groups; n (%) | Â | |
 1–5 | 7 (26.9) | |
 6–10 | 7 (26.9) | |
 11–15 | 6 (23.0) | |
 16–20 | 4 (15.3) | |
 21–25 | 2 (7.6) | |
Sex; n (%) | Â | |
 Female | 11 (42.3) | |
 Male | 15 (57.7) | |
Born premature; n (%) | Â | |
 Yes | 4 (18.2) | |
Care level; n (%)1 | Â | |
 None | 1 (3.8) | |
 1 | 0 (0) | |
 2 | 0 (0) | |
 3 | 1 (3.8) | |
 4 | 5 (19.2) | |
 5 | 19 (73.1) | |
Can the child communicate verbally?; n (%) | Â | |
 Yes, without restrictions | 2 (9.1) | |
 Yes, with restrictions | 3 (13.6) | |
 No | 17 (77.3) | |
Diagnoses2 | Â | |
 ICD-10 code | Definition of ICD 10 code and examples of underlying disease(s) | number (%) |
 P91 | Other disturbances of cerebral status of newborn | 9 (34.6) |
| Â | Hypoxic ischemic encephalopathy, Periventricular leukomalacia | Â |
 Q87 | Other specified congenital malformation syndromes affecting multiple systems | 5 (19.2) |
|  | Microdeletion syndrome 4q13.3–21.3, mosaic trisomy 9 |  |
 Q04.9 | Congenital malformation of brain, unspecified | 4 (15.4) |
| Â | Severe psychomotor developmental disorder with bifrontal polymicrogyria and hypomyelination. | Â |
 E70-E70 | Metabolic disorders | 3 (11.5) |
| Â | Metachromatic leukodystrophy | Â |
 Q93.9 | Disorder of brain, unspecified | 2 (7.7) |
| Â | Epileptic encephalopathy | Â |
 G71 | Primary disorders of muscles | 1 (3.8) |
| Â | X-linked recessive muscular dystrophy, Duchenne type | Â |
 Q89 | Other congenital malformations, not elsewhere classified | 1 (3.8) |
| Â | Severe global developmental disorder caused by mutation in the ACY1 gene. | Â |
 G93.1 | Anoxic brain damage, not elsewhere classified | 1 (3.8) |
| Â | Severe multi-cystic encephalomalacia | Â |